Stable nebulization and muco-trapping properties of regdanvimab/IN-006 support its development as a potent, dose-saving inhaled therapy for COVID-19.

Saved in:
Bibliographic Details
Title: Stable nebulization and muco-trapping properties of regdanvimab/IN-006 support its development as a potent, dose-saving inhaled therapy for COVID-19.
Authors: McSweeney, Morgan D.1,2, Stewart, Ian3, Richardson, Zach1,2, Hyunah Kang4, Yoona Park4, Cheolmin Kim4, Tiruthani, Karthik5, Wolf, Whitney5, Schaefer, Alison6, Kumar, Priya7, Aurora, Harendra7, Hutchins, Jeff1, Jong Moon Cho4, Hickey, Anthony J.3, Soo Young Lee4, Lai, Samuel K.1,2,5,6,8 lai@unc.edu
Source: Bioengineering & Translational Medicine. Jan2023, Vol. 8 Issue 1, p1-14. 14p.
Database: Academic Search Ultimate
Description
ISSN:23806761
DOI:10.1002/btm2.10391